| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 28, 2025 |
| Accession Number: | 0001628280-25-027937 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 28, 2025 |
| Accession Number: | 0001628280-25-027937 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/25/2025 | $28.00 | Buy | Needham |
| 9/12/2024 | Mkt Perform | JMP Securities | |
| 7/15/2024 | $8.00 → $6.00 | Overweight → Equal-Weight | Morgan Stanley |
| 6/26/2024 | Neutral | BTIG Research | |
| 6/11/2024 | $4.50 | Neutral | Goldman |
| 2/12/2024 | $6.00 | Buy | Citigroup |
| 1/17/2024 | $8.00 | Overweight | KeyBanc Capital Markets |
| 10/26/2023 | $6.00 | Overweight | Cantor Fitzgerald |